|Podcasts|January 7, 2022

Pharmacy Focus Episode 38: The Revolutionary Impact of Dupilumab on Skin Conditions

Author(s)Jill Murphy, Associate Editor

Dupilumab has been a breakthrough treatment for patients with atopic dermatitis, but future studies are needed to continue learning about its strength.

In this week’s episode, we will be discussing dupilumab and its impact on atopic dermatitis with Dr. Peter Lio. If you would like to nominate a pharmacist or pharmacy staff member as a Pharmacy Hero, email AAntrim@pharmacytimes.com!

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Pharmacy Focus Episode 38: The Revolutionary Impact of Dupilumab on Skin Conditions

Newsletter

Related Content

BTK Inhibitors with CAR T-cell Therapy

Lingering Muscle Damage After Weight Restoration in Anorexia Nervosa May Require Long-Term Care

Rates of Missed MMR Vaccination Have Increased Since Pandemic

Pharmacist-Led Dietary Guidance Supports Kidney Health

Regimens, Adherence, and Adverse Events: The Role of the Pharmacist in Asthma Management

Latest CME

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

Navigating Diabetes: A Guide to Effective Oral Treatments

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Hyperlipidemia Overview and the Clinical and Economic Burden

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Beyond the Spots: Management of Measles

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Tracking a Moving Target in HR+ Metastatic Breast Cancer: Innovative Oral Therapies and Evolving Strategies

An Evolving Treatment Paradigm: Innovative Approaches and Critical Insights in the Management of Newly Diagnosed Multiple Myeloma

Advancing Care in HER2-Negative Early Breast Cancer: Essential Insights and Best Practices for Oncology Pharmacists

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Transforming Lymphoma Treatment With Bispecific Antibodies: Practical Solutions for Oncology Pharmacy Teams

Navigating the World of Insulin: An Update on Types, Uses, and Considerations

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

Streamlining Pharmacist-Led Hyperglycemia Management in HR+ Breast Cancer: Overcoming PI3K/AKT Inhibitor Challenges

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

JAK(i) of All Trades: Navigating Myelofibrosis Treatment and Safety in Community Oncology Practice

Beyond Chimeric Antigen Receptor T-Cell Therapy: Comprehensive Approaches for Community Oncology Practices in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Advancing Chronic Lymphocytic Leukemia Treatment in the Community: Practical Updates and Clinical Pearls for Oncology Pharmacists

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Shaping the Future of Renal Cell Carcinoma: A Case-Based Exploration of Emerging Treatment and Improved Patient Outcomes

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights

A Deep Dive Into CGM Data (Pharmacy Technician Credit)

Continuous Glucose Monitoring: What's New in 2025? (Pharmacy Technician)

A Deep Dive Into CGM Data

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Advances and Innovations in Hypertrophic Cardiomyopathy Management: A Focus on New and Emerging Therapies

Empowering Pharmacists in Travel Medicine: Enhancing Patient Care Through Vaccination, Prevention, and Education

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases

Directions in Pharmacy 2026

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

Adapting to Advances in EGFR-Positive Non-Small Cell Lung Cancer Treatment: Critical Insights for Oncology Pharmacists

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia